FDA Authorizes Additional Presentation for Moderna Vaccine

3/29/22 — The FDA authorized a manufacturing change for the Moderna COVID-19 Vaccine to include an additional presentation of the vaccine for booster vaccination doses only.  The new presentation is supplied in multiple dose vials with dark blue caps and labels with a purple border. The Moderna COVID-19 Vaccine is now authorized for individuals 18 years of age and older in two presentations:

1) multiple dose vials with red caps and labels with a light blue border, formulated to provide doses for primary vaccination (each 0.5 mL dose containing 100 microgram mRNA) or doses for booster vaccination (each 0.25 mL dose containing 50 microgram mRNA); and

2) multiple dose vials with dark blue caps and labels with a purple border, formulated to provide doses for booster vaccination only (each 0.5 mL dose containing 50 microgram mRNA).